Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05831358 · ClinicalTrials.gov registry record · NA
Early Detection of Multiple Myeloma to Fight Cancer Disparities: A Screening and Patient Navigation Program
A NA study of Multiple Myeloma and Smoldering Multiple Myeloma, sponsored by Case Comprehensive Cancer Center.
- Active
- Registry status
- NA
- Development phase
- 201
- Enrollment target
- 1
- Study location
NCT05831358 is a NA study of Multiple Myeloma and Smoldering Multiple Myeloma that is active but no longer recruiting, run by Case Comprehensive Cancer Center. The registered enrollment target is 201 participants, below the 546-participant average among 438 other Multiple Myeloma trials with a reported enrollment target (63% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05831358, a NA study of Multiple Myeloma and Smoldering Multiple Myeloma, is active but no longer recruiting, sponsored by Case Comprehensive Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 201 participants
- Enrollment target
- 1
- Study location
Study Summary
This project will pilot the expansion of the existing Taussig Outreach Program's community outreach and patient navigation model to study the multiple myeloma (MM) screening program. This involves analyzing community reception, screening program methods, reasons patients decided to participate, reasons patients declined participation, and participant views and attitudes. This study also aims to gauge the current and general understanding of MM. This study seeks to recruit participants in the pilot screening program to promote early detection. Participants who have abnormal results will receive patient navigation for further diagnostics and testing.
Conditions Studied
Interventions
- OTHER Multiple Myeloma M-Protein Analysis
- OTHER Multiple Myeloma Knowledge Questionnaires
Study Locations (1)
Ohio
- Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 201 participants |
| Start Date | 2023-06-16 |
| Est. Completion | 2026-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05831358
The ClinicalTrials.gov registry entry for NCT05831358 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 201 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 546-participant average among 438 other Multiple Myeloma trials with a reported enrollment target (63% lower). The listed sponsor is Case Comprehensive Cancer Center, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Multiple Myeloma appearing as the primary indexed condition, and to 2 interventions - of which Multiple Myeloma M-Protein Analysis is the first listed.
NCT05831358 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT05831358 about?
NCT05831358 is a clinical study titled "Early Detection of Multiple Myeloma to Fight Cancer Disparities: A Screening and Patient Navigation Program". This project will pilot the expansion of the existing Taussig Outreach Program's community outreach and patient navigation model to study the multiple myeloma (MM) screening program. This involves analyzing community reception, screening program methods, reasons patients decided to participate, reas...
What is the current status of trial NCT05831358?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 201 participants. The study started on 2023-06-16. Estimated completion is 2026-07.
What conditions does trial NCT05831358 study?
This clinical trial studies the following conditions: Multiple Myeloma, Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance.
What interventions are being tested in trial NCT05831358?
The interventions under investigation include: Multiple Myeloma M-Protein Analysis (OTHER), Multiple Myeloma Knowledge Questionnaires (OTHER).
Who is sponsoring clinical trial NCT05831358?
This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05831358 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Multiple Myeloma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)
RECRUITING · NA
-
An AI-Generated, Personalized Question Prompt List Intervention for Patients With Hematologic Cancers
RECRUITING · NA
-
Prehabilitation Exercise Training in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation
RECRUITING · NA
-
Understanding the Mechanisms of Clonal and Non-clonal Cytopenia Following CAR-T Therapy for Multiple Myeloma or CD19+ Lymphoproliferative Disorder (LPD)
RECRUITING · NA
-
Study Using Prebiotics to Improve Gut Microbiome Diversity After Autologous Stem Cell Transplantation
RECRUITING · NA
-
Prehabilitation Feasibility Among Older Adults Undergoing Transplantation
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.